Clinical Trial Update: Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia

View source ↗

Summary

A clinical trial update evaluating the efficacy and safety of ziprasidone for depressive symptoms in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Wuhan University | Conditions: The Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores., The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales. | Status: UNKNOWN